Free Trial

Agora (API) Competitors

Agora logo
$4.00 -0.03 (-0.74%)
As of 04:00 PM Eastern

API vs. ENFN, PD, TUYA, COUR, IAS, BASE, SEMR, MLNK, AMPL, and SABR

Should you be buying Agora stock or one of its competitors? The main competitors of Agora include Enfusion (ENFN), PagerDuty (PD), Tuya (TUYA), Coursera (COUR), Integral Ad Science (IAS), Couchbase (BASE), Semrush (SEMR), MeridianLink (MLNK), Amplitude (AMPL), and Sabre (SABR). These companies are all part of the "computer software" industry.

Agora vs. Its Competitors

Enfusion (NYSE:ENFN) and Agora (NASDAQ:API) are both small-cap computer software companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation.

In the previous week, Agora had 1 more articles in the media than Enfusion. MarketBeat recorded 1 mentions for Agora and 0 mentions for Enfusion. Agora's average media sentiment score of 1.87 beat Enfusion's score of 0.00 indicating that Agora is being referred to more favorably in the news media.

Company Overall Sentiment
Enfusion Neutral
Agora Very Positive

Enfusion has higher revenue and earnings than Agora. Agora is trading at a lower price-to-earnings ratio than Enfusion, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Enfusion$201.61M6.94$6.03M$0.03361.63
Agora$133.26M2.80-$42.73M-$0.36-11.11

81.1% of Enfusion shares are owned by institutional investors. Comparatively, 40.4% of Agora shares are owned by institutional investors. 36.4% of Enfusion shares are owned by insiders. Comparatively, 14.6% of Agora shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Enfusion currently has a consensus target price of $12.25, indicating a potential upside of 12.91%. Agora has a consensus target price of $6.00, indicating a potential upside of 50.00%. Given Agora's stronger consensus rating and higher probable upside, analysts clearly believe Agora is more favorable than Enfusion.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Enfusion
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
Agora
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Enfusion has a net margin of 1.70% compared to Agora's net margin of -24.61%. Enfusion's return on equity of 6.67% beat Agora's return on equity.

Company Net Margins Return on Equity Return on Assets
Enfusion1.70% 6.67% 4.86%
Agora -24.61%-5.69%-4.74%

Enfusion has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500. Comparatively, Agora has a beta of 0.58, indicating that its stock price is 42% less volatile than the S&P 500.

Summary

Enfusion beats Agora on 10 of the 14 factors compared between the two stocks.

Get Agora News Delivered to You Automatically

Sign up to receive the latest news and ratings for API and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding API and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

API vs. The Competition

MetricAgoraTechnology Services IndustryBusiness SectorNASDAQ Exchange
Market Cap$376.14M$2.51B$19.07B$9.51B
Dividend YieldN/A1.51%2.74%4.01%
P/E RatioN/A14.5625.8320.14
Price / Sales2.8037.8049.36104.37
Price / CashN/A45.9727.3958.56
Price / Book0.655.496.265.87
Net Income-$42.73M$33.37M$197.18M$258.55M
7 Day Performance0.25%2.02%1.57%2.23%
1 Month Performance6.38%10.78%6.52%12.76%
1 Year Performance61.29%41.59%30.80%19.36%

Agora Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
API
Agora
3.521 of 5 stars
$4.00
-0.7%
$6.00
+50.0%
+61.8%$376.14M$133.26M0.001,310
ENFN
Enfusion
N/A$10.85
+0.5%
$12.25
+12.9%
+17.9%$1.40B$201.61M271.29890High Trading Volume
PD
PagerDuty
3.439 of 5 stars
$14.95
+0.5%
$19.50
+30.5%
-27.2%$1.36B$467.50M-37.361,242News Coverage
Positive News
TUYA
Tuya
0.3469 of 5 stars
$2.52
+2.2%
N/A+62.8%$1.36B$298.62M62.891,435
COUR
Coursera
2.1887 of 5 stars
$8.33
+2.9%
$9.40
+12.9%
+25.9%$1.34B$694.67M-19.361,260Trending News
Earnings Report
Analyst Forecast
Options Volume
Gap Up
IAS
Integral Ad Science
3.3173 of 5 stars
$7.99
+1.9%
$13.55
+69.6%
-20.5%$1.32B$549.64M27.55760Positive News
Upcoming Earnings
Analyst Forecast
BASE
Couchbase
1.9628 of 5 stars
$24.31
+0.0%
$23.09
-5.0%
+25.6%$1.31B$214.66M-17.74650
SEMR
Semrush
3.3855 of 5 stars
$8.73
+2.1%
$16.43
+88.3%
-31.9%$1.29B$396.02M109.091,170News Coverage
MLNK
MeridianLink
1.2481 of 5 stars
$16.33
+0.7%
$19.42
+18.9%
-28.5%$1.26B$316.30M-42.98620News Coverage
AMPL
Amplitude
1.9866 of 5 stars
$12.45
+3.2%
$13.50
+8.4%
+55.8%$1.23B$306.60M-16.38740
SABR
Sabre
1.3924 of 5 stars
$3.17
+0.3%
$4.28
+34.9%
+0.3%$1.23B$3.03B-7.206,253Trending News
Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:API) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners